Colagrossi, L, Hermans, L E, Salpini, R, Di Carlo, D, Pas, S D, Alvarez, M, Ben-Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Köse, S, Krarup, H, Lazarevic, I, Lunar, M M, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stöckl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Lepej, S Z, Weis, N, Yalcinkaya, T, Boucher, C A B, Wensing, A M J, Perno, C F, Svicher, V & HEPVIR working group of the European Society for translational antiviral research (ESAR) 2018, ' Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe ', BMC Infectious Diseases, vol. 18, no. 1, 251, pp. 1-12 . https://doi.org/10.1186/s12879-018-3161-2 BMC Infectious Diseases, 18:251. BioMed Central Ltd. BMC Infectious Diseases BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-12 (2018) HEPVIR working group of the European Society for translational antiviral research (ESAR) 2018, ' Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe ', BMC Infectious Diseases, vol. 18, no. 1, 251 . https://doi.org/10.1186/s12879-018-3161-2